Suchergebnisse - "Dallavalasa, Siva"

PubPharm (6)

1

Quality by Design Based Formulation of Xanthohumol Loaded Solid Lipid Nanoparticles with Improved Bioavailability and Anticancer Effect against PC-3 Cells

enthalten in: Pharmaceutics | 2022

von Harish, V. | Tewari, D. | Mohd, S. | +11

2

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness

enthalten in: Vaccines | 2022

von Tulimilli, S. | Dallavalasa, S. | Basavaraju, C. | +4

3

Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients

enthalten in: Vaccines | 2022

von Korishettar, G. | Chikkahonnaiah, P. | Tulimilli, S. | +4

4

ABHD11-AS1 : An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies

enthalten in: Non-coding RNA | 2022

von Golla, U. | Sesham, K. | Dallavalasa, S. | +6

5

COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy : Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19

enthalten in: Current medicinal chemistry | 2022

von Beeraka, N. | Tulimilli, S. | Greeshma, M. | +9

6

COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19

enthalten in: Current medicinal chemistry | 2022

von Beeraka, N. | Tulimilli, S. | Greeshma, M. | +9

1
[1]